INSIGHTS ON CLINICAL TRIAL PARTNERING

• Using Technology To Reduce Monitoring Costs And Increase Quality

  Join industry experts as they discuss how the true value of DDC lies not just in the cost of the technology itself but in the operational efficiencies it unlocks.

• Podcast―Nonclinical Considerations When Developing Ophthalmic Drugs

  Globally recognized consultants discuss how they are addressing the most pressing drug development topics in the ocular field.

• Meeting 100% Recruitment 7 Months Ahead Of Schedule

  Uncover the detailed outcomes of this extensive Phase 3 clinical trial on a new biosimilar for non-small cell lung cancer.

• Your Benefits To Working With A Clinical Research Marketing Agency

  Distinguish your clinical trial through partnering with a clinical research marketing agency to effectively attract and retain eligible participant with customized campaigns and digital marketing.

• Benefit From Enhanced Power And Intelligence

  8/14/2025

  Find a supply automation value engine with intelligent automation and algorithms to analyze drug supply data and automatically adjust delivery quantities to each site based on data available in IRT.

• Planning For High-Performance Hematologic Oncology Clinical Trials

  5/7/2024

  Running successful clinical trials in hematologic malignancies necessitates a deep comprehension of a swiftly evolving treatment framework that is growing more nuanced, intricate, and patient-centered.

• Central eSource Is The Latest In Sponsor Provided Site Offerings

  7/7/2025

  For decades, sponsors have provided tools to help clinical sites work more efficiently. Central eSource is the latest evolution in this trend.

• Site Engagement Improves Study Support And Results

  12/10/2025

  Dedicated site engagement helps reduce administrative burden, improve participant access, and keep studies moving. This approach strengthens workflows and supports sites throughout every phase.

• How To Optimize CMC And Clinical Strategies For Injectable, Oral Peptide Drugs

  3/17/2025

  Advances in peptide drug delivery have opened new opportunities for peptide drug products, with non-parenteral routes of administration — such as oral and nasal — now feasible.